Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity
Clinical trial NCT06756061 · RECRUITING
Trial details
- NCT number
- NCT06756061
- Sponsor
- Byung-Sik Cho
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2027-11-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.